Blog

January 12, 2022

Caretalk1-AD

    I rarely use the word “hate” but I can say that I truly hate Alzheimer’s disease. This chronic illness slowly stole my grandfather away from his family. It stole my grandfather from me, the man who was the only father figure in my life. It stole a father away from his children and […]

Read More
January 12, 2022

Using robotic pets in the treatment of dementia care

    How can technological innovation help treat symptoms of dementia? According to the Alzheimer’s Association, currently there are over 46 million people who are living in the U.S with dementia. By 2050, this number will rise to 131 million. Alzheimer’s dementia is a common disease affecting many and it is very costly to treat […]

Read More
January 12, 2022

Working Title: Serum elaidic acid may be linked to dementia

Writer: Mark Beaumont Word Count: 400-600 words Deadline: 11/20/19 What is elaidic acid? You may have never heard of elaidic acid but in all likelihood, you have heard of trans fat, another name for elaidic acid. Trans fat is commonly used in many foods that we eat in the manufacturing process not only to give it taste […]

Read More
January 12, 2022

Blood Pressure and Dementia

What is the link?  Research has shown for many years that having a diagnosis of hypertension, also known as high blood pressure, can increase one’s risk for developing dementia. By treating high blood pressure, you can reduce someone’s risk of developing dementia. That is the fascinating finding from a Johns Hopkins analysis of previously gathered […]

Read More
January 12, 2022

Mark Beaumont Assignment #3 Information Asymmetry Due 10/21/19

      In the U.S health insurance market, consumers of healthcare, the buyers, have an information advantage over insurance companies like Blue Cross/Blue Shield (BCBS), the payers. Consumers know more information about their own health conditions than the insurance providers. With this additional insight, buyers have an incentive to conceal health problems, in an […]

Read More
January 12, 2022

Mark Beaumont-IoT and the Digital Matrix Assignment #2 Due 10/7/2019

      The industrial incumbent, GE Healthcare, provides transformational medical technologies to meet the demand for increased access, enhanced quality and affordable healthcare around the world. Their worldwide technology ecosystem led to revenues of $18.3 B in 2016 having customers in 180 countries, employing over 313,000 and holding 3,960 patents highlighting their role as […]

Read More
January 12, 2022

Data Mining and Data Science: Exploration Using Data Visualization

          Mark Beaumont and Preeti Joshi 11/04/2019 Data provides the quantitative evidence that can be translated into information. This, in turn, is analyzed to draw inferences and direct strategic growth of firms.  Significant amounts of data (referred to as “big data”) are being generated due to increased connectivity across digital platforms […]

Read More
January 12, 2022

HM 717-Drugs, Devices and Diagnostics Pharmac-Respire Negotiations

      Mark C. Beaumont Richard Acheampong   Market Analysis Osteoporosis is a chronic medical disease that causes bones in the body to become weak and brittle.  As of 2015 more than 10 million Americans have osteoporosis, which is defined by the National Osteoporosis Foundation as a chronic, progressive disease characterized by low bone […]

Read More
January 12, 2022

HM717-Drugs, Diagnostics and Devices-Strategy and Execution

        Antegren Case Write Up 10/7/2020  Case summary In February 2004 Jim Mullen, the CEO of Biogen Idec, encountered difficult choices regarding Antegren, a promising drug for MS that was headed for early acceptance by the FDA. He just announced an intention to submit the BLA for Antegren within the next 90 […]

Read More